GLOBAL PATHOGEN SHIELD
DEAD

Serial Number

98625135

Owner

Flagship Pioneering, Inc.

Attorney

Christina M. Licursi

Filing Date

Jun 28, 2024

Add to watchlist:

No watchlists yet
View on USPTO

GLOBAL PATHOGEN SHIELD Trademark

Serial Number: 98625135

GLOBAL PATHOGEN SHIELD is a trademark filed by Flagship Pioneering, Inc. on June 28, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Flagship Pioneering, Inc.

55 Cambridge Parkway, Suite 800E
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

June 28, 2024

Registration Date

Not Registered

Published for Opposition

August 5, 2025

Goods & Services

Diagnostic products and devices for use in detecting and treating infectious disease, namely, medical diagnostic apparatus for detecting the presence of pathogens in bodily fluids and medical diagnostic instruments for the analysis of bodily fluids

Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare, via a consortium, collective, and initiative of companies that collaborate to globally prevent, detect, and treat infectious disease; providing a website featuring business information about recruiting participants for clinical research and maintaining a consortium relating to the prevention, infection, and detection of infectious disease; maintaining a registry of participants on the Internet for clinical research relating to the prevention, infection, and detection of infectious disease; healthcare management and consulting services in connection with infectious disease, namely, business and management consulting for healthcare providers and related businesses and consulting in the field of healthcare operations management; developing worksite specific epidemic risk scoring profiles, namely, business risk management and healthcare business risk management consultation; consulting on healthcare public relations communication strategies; new investment and business models to drive research and development and innovation in the infectious disease space, namely, business advisory services and business consultancy with regard to reducing the spread of infectious diseases

Providing an on-line computer database featuring medical research information in the field of infectious disease; research and development in the field of infectious diseases for research facilities and vaccine manufacturing facilities; research and development in the field of pharmaceutical and therapeutic development and medical device development; clinical research services in the field of medical care, namely, conducting clinical trials for others and scientific research; medical research in the nature of conducting laboratory, clinical and public health research, all for the medical and biomedical fields in the fields of infectious diseases and vaccines sciences, population science, and health systems research; providing temporary use of online, non-downloadable software for tracking and reporting incidence of infectious disease; providing temporary use of online, non-downloadable software for use in the analysis of health and environmental data; providing temporary use of online, non-downloadable software for use in the analysis of healthcare data from patients to determine rates, trends, patterns, and causative factors contributing to incidence of infectious disease; scientific and medical research in the fields of health, healthcare, infection prevention and control, and infectious diseases; product research, design and development in the fields of health, healthcare, infection prevention and control, and infectious diseases; product research, design and development of medical devices, products and technologies in the fields of health, healthcare, infection prevention and control, and infectious diseases; design and development of healthcare products to improve healthcare services and build health systems; quality management services, namely, quality evaluation and analysis, quality assurance, quality control and product quality improvement being product quality evaluation, all in the fields of health, healthcare, infection prevention and control, and infectious diseases; developing quality control and voluntary standards and guidelines being protocols, namely, developing quality control and voluntary standards to address exposure to infectious disease, all for the delivery and rendition of healthcare services; developing worksite specific epidemic risk scoring profiles in the nature of scientific research consultation in the field of infectious diseases; developing intervention protocols, namely, development of voluntary standards for addressing exposure of infectious disease; research tools, namely, providing temporary use of online, non-downloadable software for use in conducting infectious disease and public health research; research tools, namely, providing an online searchable databases in the field of infectious disease and public health medical and scientific research; scientific collaboration tools and services for researching and testing treatments for infectious disease, namely, providing temporary use of a non-downloadable web application for collaborating on shared documents and data; surveillance tools and services for infectious disease being tools for monitoring infectious disease, namely, providing temporary use of online non-downloadable software for use in environmental monitoring and sampling air or surfaces

Subscription-based security system to prevent, detect, treat infectious disease being emergency response alarm monitoring services, namely, monitoring of alert devices by a remote monitoring center for the dispatch of emergency public health services and notification to third parties

diagnostic products and devices for use in detecting infectious disease, namely, diagnostic apparatus for the detection of pathogens for laboratory and research use, not for medical purposes; downloadable software for tracking and reporting incidence of infectious disease; downloadable software for use in the analysis of health and environmental data; downloadable software for use in the analysis of healthcare data from patients to determine rates, trends, patterns, and causative factors contributing to incidence of infectious disease; research and development tools relating to infectious diseases for research facilities and vaccine manufacturing facilities, namely, research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; scientific collaboration tools for researching and testing treatments for infectious disease, namely, downloadable computer software for collaborating on shared documents and data; electronic tools in the nature of downloadable software used to predict, identify and characterize pathogen threats to individuals and populations

Providing a website featuring medical and health information about infectious disease; providing an on-line computer database featuring medical and health information in the field of infectious disease; subscription-based security system to prevent, detect, treat infectious disease, namely, providing an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions; consulting services in the field of healthcare in connection with infectious disease; developing worksite specific epidemic risk scoring profiles in the nature of healthcare consultation in the field of infectious diseases; providing a website featuring healthcare information about recruiting participants for clinical research and maintaining a consortium relating to the prevention, infection, and detection of infectious disease; new investment and business models to drive research and development and innovation in the infectious disease space, namely, healthcare advisory services and healthcare consultancy with regard to reducing the spread of infectious diseases

Educational services, namely, conducting classes, seminars, and workshops in the field of public health and research and development related to infectious disease and distribution of educational materials in connection therewith; education services, namely, providing on-line instruction in the field of public health and the prevention, infection, and detection of infectious disease via an online website; educational services, namely, conducting classes, seminars, conferences and workshops in the fields of pharmaceutical and biotechnological product development, medical device development, public health, chronic diseases, infectious diseases, and economic development; educational services, namely, developing curriculum for others in the field of medical research; developing trainings in the nature of training systems for others regarding safety and health measures and preparing screening and monitoring protocols to address exposure to infectious disease

Diagnostic products for use in detecting and treating infectious disease, namely, medical diagnostic reagents and diagnostic preparations for medical purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 4, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 4, 2026 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 30, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 5, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 5, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 27, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 27, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 27, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 27, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 27, 2025 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 25, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 25, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 25, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 29, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 29, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 29, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 30, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 30, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 30, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 27, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 28, 2024 NWOS
NEW APPLICATION ENTERED
Jun 28, 2024 NWAP